Q: HI GUYS I was wondering if this company would be ok to buy because the price seems fair and it pays good divivdend, I cant find any news on it or do you have anything else in that price range that may be worth looking at. I am looking to buy it in my tfsa thanks so much Larry
Q: Hi Team
I started a position in this ETF today. What do you think for a long term hold. Obviously the Sector will be huge in the future,
Thanks Gord
Q: Discovered this Long Term Care Properties company in the US with monthly dividends of 6%. Do you think this is a stock worth holding to have exposure to US health care? And is dividend sustainable as it seems to have a large payout from my novice analysis. Appreciate your expert analysis very much.
Q: DRDR just reported their last quarter. While sales are going up, they never seem to make any money, even EBITDA negative. Your thoughts please. Thanks
Q: Any comments or opinions about today's announced bought deal of new shares of Well? The offering price seems low, it looks as though they waited for a dip to make the offering. Are we existing shareholders getting a raw deal?
Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?
Q: Good Morning
Can you please give your opinion on Harvest Healthcare Leaders ETF or is there another healthcare purchase you would suggest.
Also would this be a good time to purchase.
Thank you
Heather
Q: there's some fringe companies doing experiments with magic mushrooms to treat anxiety, depression and a number of other ailments. If this takes off do you think this could have lots of upside , or will this be attacked by large drug makers whose patented drugs could loose market share ? Thanks alot.
Q: To me WELL is hitting on all cylinders but it is unloved within the market. This from it's latest results:
WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis
I have held it for a while now and am under water. Granted we are in a down market but do you think this stock will get more attention once the market hits bottom [when ever that is] and starts to move up?